PE20040698A1 - Derivados de isoindolina - Google Patents
Derivados de isoindolinaInfo
- Publication number
- PE20040698A1 PE20040698A1 PE2003001193A PE2003001193A PE20040698A1 PE 20040698 A1 PE20040698 A1 PE 20040698A1 PE 2003001193 A PE2003001193 A PE 2003001193A PE 2003001193 A PE2003001193 A PE 2003001193A PE 20040698 A1 PE20040698 A1 PE 20040698A1
- Authority
- PE
- Peru
- Prior art keywords
- ona
- dimethyl
- phenyl
- piperazinil
- alkyl
- Prior art date
Links
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical class C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 title 1
- -1 PYRIMIDINYL Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- 230000003444 anaesthetic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 abstract 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 abstract 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/62—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles
- C07D209/64—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A DERIVADOS DE INDAZOL DE FORMULA (I), EN DONDE LOS R1 SON DE 1 A 3 GRUPOS IGUALES O DIFERENTES, DE ALQUILO(C1-C3) Y ALCOXI(C1-C3), O CUANDO LOS R1 SON DOS GRUPOS ADYACENTES, JUNTOS PUEDEN FORMAR UN GRUPO CICLICO DE 5-6 MIEMBROS, SATURADO O NO, CON 1 A 2 HETEROATOMOS DE S, N Y O; X ES O o S; R2 ES FENILO, BENCILO, PIRIDILO, PIRIDILMETILO, PIRIMIDINILO, ENTRE OTROS, TODOS OPCIONALMENTE SUSTITUIDOS; SIEMPRE QUE SI R2 ES FENILO, LAS POSICIONES 3 Y 4 DEL FENILO NO ESTEN SIMULTANEAMENTE SUSTITUIDAS POR GRUPOS ALCOXI; LA LINEA PUNTEADA REPRESENTA UN ENLACE SIMPLE O DOBLE ENLACE; L ES (CH2)n-H DONDE n ES DE 1 A 8, -(CH2)n'-PIPERAZINIL-R3, -(CH2)n"-CW-A, DONDE W ES O o S, A ES ALQUILO(C1-C5), 2-DIMETILAMINOETILAMINO, 2-TIAZOLILAMINO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 5,6-DIMETIL-2-(3-FLUROFENIL)-3-(4-METIL-1-PIPERAZINIL)CARBONILMETILISOINDOLIN-1-ONA O ACIDO 2-[2-(4-FLUOROFENIL)-5,6-DIMETIL-3-OXO-2,3-DIHIDRO-1H-ISOINDOL-1-IL]ACETICO], 5,6-DIMETIL-2-(4-FLUOROFENIL)-3-(4-METIL-1-PIPERAZINIL)-CARBONILETILISOINDOLIN-1-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A COMPOSICION FARMACEUTICA PARA SER ADMINISTRADA POR VIA ENDOVENOSA. ESTOS COMPUESTOS SON UTILES PARA INDUCIR UN EFECTO SEDANTE Y ANESTESICO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002342399 | 2002-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040698A1 true PE20040698A1 (es) | 2004-10-30 |
Family
ID=32375878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003001193A PE20040698A1 (es) | 2002-11-26 | 2003-11-25 | Derivados de isoindolina |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7521451B2 (es) |
| EP (1) | EP1566378B1 (es) |
| KR (1) | KR101149978B1 (es) |
| CN (1) | CN100548980C (es) |
| AR (1) | AR042139A1 (es) |
| AU (1) | AU2003284669B2 (es) |
| BR (1) | BR0316645A (es) |
| CA (1) | CA2505029C (es) |
| DK (1) | DK1566378T3 (es) |
| EC (1) | ECSP055886A (es) |
| ES (1) | ES2393645T3 (es) |
| IL (1) | IL168477A (es) |
| MX (1) | MXPA05005580A (es) |
| NO (1) | NO333165B1 (es) |
| NZ (1) | NZ539834A (es) |
| PE (1) | PE20040698A1 (es) |
| PL (1) | PL376890A1 (es) |
| PT (1) | PT1566378E (es) |
| RU (1) | RU2343145C2 (es) |
| TW (1) | TWI320408B (es) |
| UY (1) | UY28094A1 (es) |
| WO (1) | WO2004048332A1 (es) |
| ZA (1) | ZA200503697B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005245292A1 (en) * | 2004-05-24 | 2005-12-01 | Maruishi Pharmaceutical Co., Ltd. | Neurogenic pain control agent composition |
| CN101316836A (zh) * | 2005-11-01 | 2008-12-03 | 詹森药业有限公司 | 作为葡萄糖激酶变构调节剂的取代的二氢异吲哚酮类 |
| US8110681B2 (en) | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| CN101490002A (zh) * | 2006-07-12 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | 作为止痛剂的3-氧代异二氢吲哚-1-甲酰胺衍生物 |
| TWI417100B (zh) * | 2007-06-07 | 2013-12-01 | Astrazeneca Ab | 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途 |
| CA2700841A1 (en) * | 2007-09-27 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| GB0811643D0 (en) | 2008-06-25 | 2008-07-30 | Cancer Rec Tech Ltd | New therapeutic agents |
| US9682967B2 (en) | 2013-01-28 | 2017-06-20 | H. Lundbeck A/S | N-substituted-5-substituted phthalamic acids as sortilin inhibitors |
| CN105254554B (zh) * | 2014-07-14 | 2018-01-30 | 南开大学 | 一种制备异吲哚啉酮类化合物的方法 |
| CN104803905B (zh) * | 2015-04-17 | 2017-10-10 | 复旦大学 | 一种合成异吲哚啉‑1‑酮衍生物的方法 |
| ITRM20150196A1 (it) * | 2015-05-05 | 2016-11-05 | Univ Degli Studi Di Salerno | Isoindolinoni, procedimenti per la produzione di loro derivati chirali e impiego di questi ultimi |
| GB201517217D0 (en) | 2015-09-29 | 2015-11-11 | Astex Therapeutics Ltd And Cancer Res Technology Ltd | Pharmaceutical compounds |
| GB201517216D0 (en) | 2015-09-29 | 2015-11-11 | Cancer Res Technology Ltd And Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704966D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704965D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| CN110698445B (zh) * | 2018-07-09 | 2023-05-12 | 四川大学 | 一类3-胺烷基苯酞类化合物、其制备方法和用途 |
| WO2021041664A1 (en) * | 2019-08-27 | 2021-03-04 | The Regents Of The University Of Michigan | Cereblon e3 ligase inhibitors |
| CN110498759A (zh) * | 2019-09-12 | 2019-11-26 | 天津瑞岭化工有限公司 | 异吲哚啉酮类化合物的合成方法 |
| WO2021143822A1 (zh) * | 2020-01-16 | 2021-07-22 | 江苏恒瑞医药股份有限公司 | 并环酰亚胺类衍生物、其制备方法及其在医药上的应用 |
| WO2021143816A1 (zh) * | 2020-01-16 | 2021-07-22 | 江苏恒瑞医药股份有限公司 | 稠合酰亚胺类衍生物、其制备方法及其在医药上的应用 |
| CN114539124B (zh) * | 2022-02-28 | 2023-07-21 | 大连大学 | 一种对映选择性合成n,3-二取代-1-异吲哚啉酮化合物的方法 |
| CN114394926B (zh) * | 2022-02-28 | 2023-06-27 | 大连大学 | N,3-二取代-1-异吲哚啉酮类化合物的高产率合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2101081B1 (es) * | 1970-08-19 | 1974-01-11 | Rhone Poulenc Sa | |
| US3679686A (en) * | 1970-09-09 | 1972-07-25 | Janssen Pharmaceutica Nv | N-(bicycloamino-alkanoyl)-anilines |
| FR2117740B1 (es) | 1970-12-14 | 1974-04-12 | Rhone Poulenc Sa | |
| JPS4712322U (es) | 1971-03-09 | 1972-10-13 | ||
| GB1472793A (en) | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
| OA05287A (fr) | 1975-04-07 | 1981-02-28 | Rhone Poulenc Ind | Nouveaux composés hétérocycliques et leur préparation. |
| ATE39483T1 (de) | 1982-04-02 | 1989-01-15 | Takeda Chemical Industries Ltd | Kondensierte pyrrolinon-derivate, und ihre herstellung. |
| WO1983003410A1 (fr) * | 1982-04-02 | 1983-10-13 | Takeda Chemical Industries Ltd | Derives d'isoindoline |
| JPS58189163A (ja) | 1982-04-02 | 1983-11-04 | Takeda Chem Ind Ltd | 縮合ピロリノン誘導体 |
| US5932613A (en) | 1996-07-03 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Anticancer agents |
| KR19980074060A (ko) | 1997-03-21 | 1998-11-05 | 김윤배 | 신규한 치환된 3,4-디알콕시페닐 유도체 |
| JP2002512633A (ja) * | 1997-06-26 | 2002-04-23 | イーライ・リリー・アンド・カンパニー | 抗血栓剤 |
| AU777517B2 (en) | 1999-06-10 | 2004-10-21 | Bridge Pharma, Inc. | Dermal anesthetic agents |
| AU2005245292A1 (en) * | 2004-05-24 | 2005-12-01 | Maruishi Pharmaceutical Co., Ltd. | Neurogenic pain control agent composition |
-
2003
- 2003-11-25 ES ES03774195T patent/ES2393645T3/es not_active Expired - Lifetime
- 2003-11-25 KR KR1020057009070A patent/KR101149978B1/ko not_active Expired - Fee Related
- 2003-11-25 UY UY28094A patent/UY28094A1/es not_active Application Discontinuation
- 2003-11-25 PE PE2003001193A patent/PE20040698A1/es not_active Application Discontinuation
- 2003-11-25 AR ARP030104343A patent/AR042139A1/es not_active Application Discontinuation
- 2003-11-25 BR BR0316645-7A patent/BR0316645A/pt not_active IP Right Cessation
- 2003-11-25 EP EP03774195A patent/EP1566378B1/en not_active Expired - Lifetime
- 2003-11-25 NZ NZ539834A patent/NZ539834A/en not_active IP Right Cessation
- 2003-11-25 CA CA2505029A patent/CA2505029C/en not_active Expired - Fee Related
- 2003-11-25 PT PT03774195T patent/PT1566378E/pt unknown
- 2003-11-25 PL PL376890A patent/PL376890A1/pl not_active Application Discontinuation
- 2003-11-25 CN CNB2003801091898A patent/CN100548980C/zh not_active Expired - Fee Related
- 2003-11-25 DK DK03774195.6T patent/DK1566378T3/da active
- 2003-11-25 TW TW092133012A patent/TWI320408B/zh not_active IP Right Cessation
- 2003-11-25 MX MXPA05005580A patent/MXPA05005580A/es active IP Right Grant
- 2003-11-25 WO PCT/JP2003/014986 patent/WO2004048332A1/ja not_active Ceased
- 2003-11-25 AU AU2003284669A patent/AU2003284669B2/en not_active Ceased
- 2003-11-25 US US10/534,414 patent/US7521451B2/en not_active Expired - Fee Related
- 2003-11-25 RU RU2005120003/04A patent/RU2343145C2/ru not_active IP Right Cessation
- 2003-11-25 ZA ZA200503697A patent/ZA200503697B/en unknown
-
2005
- 2005-05-09 IL IL168477A patent/IL168477A/en not_active IP Right Cessation
- 2005-05-26 NO NO20052529A patent/NO333165B1/no not_active IP Right Cessation
- 2005-06-22 EC EC2005005886A patent/ECSP055886A/es unknown
-
2008
- 2008-12-30 US US12/318,453 patent/US20090170835A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040698A1 (es) | Derivados de isoindolina | |
| DK0778834T3 (da) | Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2 | |
| PE20020506A1 (es) | Derivados de pirazol fusionados como inhibidores de la proteina cinasa | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| ES2100907T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion. | |
| UA44254C2 (uk) | Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція | |
| EA200401056A1 (ru) | Комбинация, содержащая производные тропана, полезные в терапии | |
| YU56192A (sh) | Heterociklični derivati | |
| RU2291860C3 (ru) | Производные 2-оксо-1-пирролидина, способ их получения и применения | |
| EA200500377A1 (ru) | Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf) | |
| DE69011318D1 (de) | Diazinderivate als Angiotensin II Rezeptor Antagonisten. | |
| EA200400223A1 (ru) | Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента | |
| BR0108816A (pt) | Derivados de quinolina como antagonistas alfa-2 | |
| PE20020602A1 (es) | Derivados de fenilcetona sustituidos como antagonistas del receptor de prostaglandina i2 (ip) | |
| ATE192152T1 (de) | Piperidinderivate mit paf antagonistischer wirkung | |
| EA200400475A1 (ru) | Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли | |
| CA2216664A1 (fr) | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| NO20050573L (no) | 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler | |
| DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
| IT1256320B (it) | Derivati eterociclici | |
| SE8102220L (sv) | Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel | |
| AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
| AR035247A1 (es) | Derivados de piperidinacarboxamida, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen | |
| DK0541263T3 (da) | 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister | |
| EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |